Soligenix
SNGX
#10276
Rank
ยฃ9.21 M
Marketcap
ยฃ0.91
Share price
-4.58%
Change (1 day)
-50.88%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.37. In 2024 the company made an earnings per share (EPS) of -ยฃ3.64 an increase over its 2023 EPS that were of -ยฃ9.25.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-33.16%
2024-ยฃ3.64-60.66%
2023-ยฃ9.25-83.55%
2022-ยฃ56.2413.95%
2021-ยฃ49.35-56.03%
2020-ยฃ112.2433.33%
2019-ยฃ84.18-29.41%
2018-ยฃ119.25-41.38%
2017-ยฃ203.4324.73%
2016-ยฃ163.09-69%
2015-ยฃ526.11-6.25%
2014-ยฃ561.19-50.77%
2013-ยฃ1,14075.68%
2012-ยฃ648.8768.18%
2011-ยฃ385.81-69.86%
2010-ยฃ1,280-8.75%
2009-ยฃ1,40333.33%
2008-ยฃ1,052-57.14%
2007-ยฃ2,455-46.15%
2006-ยฃ4,56044.44%
2005-ยฃ3,157-40.7%
2004-ยฃ5,324-15.62%
2003-ยฃ6,309-25.52%
2002-ยฃ8,471-80.94%
2001-ยฃ44,443160.89%
2000-ยฃ17,035-40.57%
1999-ยฃ28,662-63.84%
1998-ยฃ79,267601.73%
1997-ยฃ11,296101.7%
1996-ยฃ5,600

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ7.63-422.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.26-153.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ2.71-214.37%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.69-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.48-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.46-119.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.03-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA